Vitamin D in Pregnancy: Benefits for Maternal and Infant Health

A significant umbrella meta-analysis published in the European Medical Journal on April 18, 2026, has highlighted the crucial role of vitamin D supplementation during pregnancy, linking it to a range of favourable maternal and neonatal outcomes. This comprehensive review, encompassing data from over 188,000 participants, suggests that adequate vitamin D levels can mitigate the risks of several pregnancy complications and improve infant health metrics. The study's findings indicate that prenatal vitamin D supplementation is associated with a lowered risk of gestational diabetes, preeclampsia, preterm delivery, low birth weight, neonates being small for gestational age, stillbirth, and neonatal mortality. Furthermore, it was observed to enhance birth weight, birth length, and head circumference in newborns. In certain subgroups, supplementation was also linked to a reduced risk of caesarean deliveries. These positive outcomes were consistent across lower vitamin D doses, shorter intervention periods, and among older participants. These claims are largely corroborated by other credible sources, although some present more nuanced perspectives. The World Health Organization (WHO) states that vitamin D supplementation during pregnancy can improve maternal vitamin D status and may reduce the risk of pre-eclampsia, low birthweight, and preterm birth. A Cochrane review from July 2024 similarly suggests that vitamin D supplementation may help improve maternal and neonatal health outcomes, such as fewer preterm births and low birthweight babies, and could reduce the risk of severe postpartum haemorrhage. Another Cochrane update also concluded that vitamin D supplementation alone likely reduces the risk of pre-eclampsia, gestational diabetes, and low birthweight. However, some meta-analyses, such as one published in Oxford Academic in July 2024, found no effect of antenatal vitamin D supplementation on the risk of preeclampsia, preterm birth, small-for-gestational-age, or low birth weight infants, while noting a potential protective effect against gestational diabetes and an increase in infant birth weight. This variation underscores the complexity of research in this area and the ongoing need for more definitive studies. Vitamin D deficiency during pregnancy is a significant global public health concern, with prevalence rates ranging widely from 9% to 94% depending on various factors like country, race, ethnicity, skin colour, clothing customs, and dietary intake. In India, the situation is particularly critical. Multiple studies highlight an alarmingly high prevalence of vitamin D deficiency among pregnant women across various regions, ranging from 42% to as high as 96%. Factors such as insufficient sun exposure despite living in a tropical country, dietary habits, and genetic predispositions contribute to this widespread deficiency. The implications of vitamin D deficiency extend beyond bone health, influencing immune function, metabolism, inflammation, and vascular health during pregnancy. Untreated deficiency can lead to adverse health problems for both the mother and the newborn, including gestational diabetes and preeclampsia for the mother, and poor fetal growth, neonatal development issues, and childhood rickets for the infant. Regarding optimal dosage, there is a developing consensus. While many prenatal vitamins contain lower doses (e.g., 400 IU), several studies suggest higher daily doses are more effective in achieving and maintaining sufficient vitamin D levels. A systematic review of randomised controlled trials up to May 2024 indicated that supplementation of 4000 IU/day was found to be safe and most effective in achieving maternal and neonatal vitamin D sufficiency, with doses of ≥2000 IU/day also showing effectiveness in correcting deficiency. Another study highlighted that 4000 IU/day could normalize vitamin D metabolism and improve birth outcomes without adverse side effects. Indian guidelines recommend at least 1000 IU daily, aiming for serum levels above 50 nmol/L. Some studies from India suggest that current recommended doses might be inadequate to correct existing deficiencies in all women. While the European Medical Journal article acknowledges the value of vitamin D supplementation as an important component of prenatal care, it also cautions that it does not equate to a definitive prevention of all adverse events. Researchers advocate for further exploration into optimal and safe dosages, appropriate supplementation protocols, the ideal timing to initiate the intervention around pregnancy, and the effects of vitamin D when taken alongside other supplements. For an Indian audience, this news is highly relevant given the prevalent deficiency and the potential for improving maternal and infant health outcomes. Healthcare providers in India should consider screening for vitamin D deficiency during pregnancy and recommend appropriate supplementation based on individual needs and current national and international guidelines. It is crucial for pregnant women to consult their doctors before starting any new supplements to ensure safe and effective dosages.

Frequently Asked Questions

Read Full Story on Quick Digest